Derivation and Characterization of a Dengue Type 1 Host Range-Restricted Mutant Virus That Is Attenuated and Highly Immunogenic in Monkeys
Open Access
- 1 April 2002
- journal article
- research article
- Published by American Society for Microbiology in Journal of Virology
- Vol. 76 (7), 3318-3328
- https://doi.org/10.1128/jvi.76.7.3318-3328.2002
Abstract
We recently described the derivation of a dengue serotype 2 virus (DEN2mutF) that exhibited a host range-restricted phenotype; it was severely impaired for replication in cultured mosquito cells (C6/36 cells). DEN2mutF virus had selected mutations in genomic sequences predicted to form a 3′ stem-loop structure (3′-SL) that is conserved among all flavivirus species. The 3′-SL constitutes the downstream terminal ∼95 nucleotides of the 3′ noncoding region in flavivirus RNA. Here we report the introduction of these same mutational changes into the analogous region of an infectious DNA derived from the genome of a human-virulent dengue serotype 1 virus (DEN1), strain Western Pacific (DEN1WP). The resulting DEN1 mutant (DEN1mutF) exhibited a host range-restricted phenotype similar to that of DEN2mutF virus. DEN1mutF virus was attenuated in a monkey model for dengue infection in which viremia is taken as a correlate of human virulence. In spite of the markedly reduced levels of viremia that it induced in monkeys compared to DEN1WP, DEN1mutF was highly immunogenic. In addition, DEN1mutF-immunized monkeys retained high levels of neutralizing antibodies in serum and were protected from challenge with high doses of the DEN1WP parent for as long as 17 months after the single immunizing dose. Phenotypic revertants of DEN1mutF and DEN2mutF were each detected after a total of 24 days in C6/36 cell cultures. Complete nucleotide sequence analysis of DEN1mutF RNA and that of a revertant virus, DEN1mutFRev, revealed that (i) the DEN1mutF genome contained no additional mutations upstream from the 3′-SL compared to the DEN1WP parent genome and (ii) the DEN1mutFRev genome contained de novo mutations, consistent with our previous hypothesis that the defect in DEN2mutF replication in C6/36 cells was at the level of RNA replication. A strategy for the development of a tetravalent dengue vaccine is discussed.Keywords
This publication has 33 references indexed in Scilit:
- A cross-reactive neutralizing monoclonal antibody protects mice from H5N1 and pandemic (H1N1) 2009 virus infectionAntiviral Research, 2010
- In Vitro RNA Synthesis from Exogenous Dengue Viral RNA Templates Requires Long Range Interactions between 5′- and 3′-Terminal Regions That Influence RNA StructureJournal of Biological Chemistry, 2001
- A Live Attenuated Dengue-L Vaccine Candidate (45AZ5) Passaged In Primary Dog Kidney Cell Culture Is Attenuated And Immunogenic For HumansThe Journal of Infectious Diseases, 1994
- Targeted Recombination-Based Cloning and Manipulation of Large DNA Segments in YeastMethods, 1993
- Detection of stable secondary structure at the 3′ terminus of dengue virus type 2 RNAGene, 1991
- FLAVIVIRUS GENOME ORGANIZATION, EXPRESSION, AND REPLICATIONAnnual Review of Microbiology, 1990
- Role of a bulged A residue in a specific RNA-protein interactionBiochemistry, 1987
- Localization of the binding site for protein S4 on 16 S ribosomal RNA by chemical and enzymatic probing and primer extensionJournal of Molecular Biology, 1986
- Analysis of Structural Properties which Possibly Are Characteristic for the 3'-Terminal Sequence of the Genome RNA of FlavivirusesJournal of General Virology, 1986
- Stable secondary structures at the 3'‐end of the genome of yellow fever virus (17 D vaccine strain)FEBS Letters, 1985